ＮＪＳの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/03/03 | 1,425 | 1,432 | 1,414 | 1,430 | +8 | +0.6% | 4,500 |
| 2017/03/02 | 1,425 | 1,425 | 1,415 | 1,422 | -3 | -0.2% | 6,200 |
| 2017/03/01 | 1,426 | 1,428 | 1,418 | 1,425 | -1 | -0.1% | 6,400 |
| 2017/02/28 | 1,418 | 1,427 | 1,415 | 1,426 | +7 | +0.5% | 5,200 |
| 2017/02/27 | 1,414 | 1,419 | 1,406 | 1,419 | +5 | +0.4% | 8,400 |
| 2017/02/24 | 1,414 | 1,414 | 1,404 | 1,414 | ±0 | ±0% | 5,600 |
| 2017/02/23 | 1,398 | 1,414 | 1,396 | 1,414 | +16 | +1.1% | 8,400 |
| 2017/02/22 | 1,399 | 1,399 | 1,392 | 1,398 | -1 | -0.1% | 3,800 |
| 2017/02/21 | 1,386 | 1,400 | 1,386 | 1,399 | +1 | +0.1% | 12,300 |
| 2017/02/20 | 1,385 | 1,400 | 1,385 | 1,398 | -1 | -0.1% | 3,300 |
| 2017/02/17 | 1,399 | 1,399 | 1,394 | 1,399 | ±0 | ±0% | 5,700 |
| 2017/02/16 | 1,390 | 1,400 | 1,381 | 1,399 | +9 | +0.6% | 10,800 |
| 2017/02/15 | 1,393 | 1,393 | 1,387 | 1,390 | -3 | -0.2% | 10,400 |
| 2017/02/14 | 1,394 | 1,396 | 1,389 | 1,393 | +17 | +1.2% | 9,900 |
| 2017/02/13 | 1,388 | 1,390 | 1,329 | 1,376 | -13 | -0.9% | 28,800 |
| 2017/02/10 | 1,386 | 1,390 | 1,383 | 1,389 | +16 | +1.2% | 11,800 |
| 2017/02/09 | 1,373 | 1,380 | 1,354 | 1,373 | ±0 | ±0% | 6,200 |
| 2017/02/08 | 1,356 | 1,374 | 1,356 | 1,373 | +3 | +0.2% | 6,100 |
| 2017/02/07 | 1,357 | 1,375 | 1,357 | 1,370 | -1 | -0.1% | 14,400 |
| 2017/02/06 | 1,376 | 1,376 | 1,359 | 1,371 | -5 | -0.4% | 3,500 |
| 2017/02/03 | 1,370 | 1,382 | 1,370 | 1,376 | +2 | +0.1% | 13,300 |
| 2017/02/02 | 1,373 | 1,375 | 1,373 | 1,374 | -11 | -0.8% | 2,400 |
| 2017/02/01 | 1,370 | 1,390 | 1,370 | 1,385 | +16 | +1.2% | 7,600 |
| 2017/01/31 | 1,358 | 1,369 | 1,358 | 1,369 | +4 | +0.3% | 3,200 |
| 2017/01/30 | 1,367 | 1,370 | 1,360 | 1,365 | -2 | -0.1% | 4,500 |
| 2017/01/27 | 1,380 | 1,380 | 1,363 | 1,367 | +7 | +0.5% | 3,400 |
| 2017/01/26 | 1,382 | 1,390 | 1,323 | 1,360 | -23 | -1.7% | 10,600 |
| 2017/01/25 | 1,381 | 1,383 | 1,375 | 1,383 | +13 | +0.9% | 9,900 |
| 2017/01/24 | 1,382 | 1,383 | 1,369 | 1,370 | -13 | -0.9% | 5,000 |
| 2017/01/23 | 1,378 | 1,385 | 1,377 | 1,383 | +5 | +0.4% | 5,600 |
| 2017/01/20 | 1,372 | 1,381 | 1,368 | 1,378 | +6 | +0.4% | 3,800 |
| 2017/01/19 | 1,358 | 1,376 | 1,345 | 1,372 | +1 | +0.1% | 9,000 |
| 2017/01/18 | 1,368 | 1,374 | 1,363 | 1,371 | +19 | +1.4% | 10,000 |
| 2017/01/17 | 1,350 | 1,361 | 1,340 | 1,352 | -26 | -1.9% | 12,100 |
| 2017/01/16 | 1,373 | 1,378 | 1,372 | 1,378 | +5 | +0.4% | 4,000 |
| 2017/01/13 | 1,370 | 1,384 | 1,369 | 1,373 | +3 | +0.2% | 12,800 |
| 2017/01/12 | 1,357 | 1,382 | 1,352 | 1,370 | +13 | +1% | 11,200 |
| 2017/01/11 | 1,354 | 1,370 | 1,354 | 1,357 | -27 | -2% | 11,100 |
| 2017/01/10 | 1,394 | 1,400 | 1,379 | 1,384 | -10 | -0.7% | 9,200 |
| 2017/01/06 | 1,396 | 1,400 | 1,382 | 1,394 | -3 | -0.2% | 9,400 |
| 2017/01/05 | 1,404 | 1,404 | 1,395 | 1,397 | -1 | -0.1% | 7,600 |
| 2017/01/04 | 1,386 | 1,403 | 1,386 | 1,398 | +12 | +0.9% | 13,000 |
| 2016/12/30 | 1,385 | 1,386 | 1,365 | 1,386 | +7 | +0.5% | 5,700 |
| 2016/12/29 | 1,365 | 1,381 | 1,365 | 1,379 | +7 | +0.5% | 8,300 |
| 2016/12/28 | 1,338 | 1,381 | 1,333 | 1,372 | -18 | -1.3% | 15,200 |
| 2016/12/27 | 1,385 | 1,392 | 1,385 | 1,390 | -8 | -0.6% | 6,000 |
| 2016/12/26 | 1,405 | 1,405 | 1,386 | 1,398 | -5 | -0.4% | 10,500 |
| 2016/12/22 | 1,399 | 1,403 | 1,396 | 1,403 | -1 | -0.1% | 9,600 |
| 2016/12/21 | 1,401 | 1,415 | 1,401 | 1,404 | +6 | +0.4% | 6,500 |
| 2016/12/20 | 1,396 | 1,400 | 1,390 | 1,398 | +3 | +0.2% | 10,600 |
1851～
1900
件表示中 / 5390件
類似銘柄と比較する
現在ご覧いただいている「ＮＪＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＮＪＳ | 350,000円 | +2.2% | +73.1% | 2.71% | 15.86倍 | 1.25倍 |
|
上下水道のコンサルタント。官公需がほとんど。調査から設計・施工監理まで一貫。海外拠点多数 |
| ＷＤＢ | 175,900円 | +5.1% | -13.4% | 3.44% | 11.63倍 | 1.15倍 |
|
理学系研究職や研究補助職の人材派遣で首位。医薬品開発受託（ＣＲＯ）や医薬関連事務も |
| ＩＴＭ | 167,300円 | +7.9% | +3.1% | 5.98% | 20.79倍 | 3.31倍 |
|
ＩＴ系ネットメディア運営。各種広告展開。営業見込み客情報提供するリードジェンを強化中 |
| クリーク＆リバ | 150,800円 | +10.4% | +16.0% | 2.85% | 10.29倍 | 2.05倍 |
|
テレビ・ゲーム・Ｗｅｂ・広告等の派遣、制作が主。医療ほか専門職分野拡大。配当性向３０％メド |
| アイロムＧ | 278,500円 | - | - | - | - | 2.64倍 |
|
ＳＭＯ（医療機関向け治験支援）主力。日・豪でＣＲＯ（医薬品開発受託）。ＭＢＯ実施準備 |
市場注目の銘柄
チャート関連のコラム
